Do you have chronic
(ongoing) kidney disease?

Do you also have anemia that needs to be treated?
We are looking for patients to join the PRO2TECT – CORRECTION Study
The PRO2TECT – CORRECTION Study will compare vadadustat, an investigational (potential new) medication, to an existing, approved anemia medication, given by injection. The potential new medication is taken by mouth.
You may be able to take part in this study if you:
• are 18 years of age or older
• have chronic kidney disease (CKD) but you are not on dialysis
• do not already take a medication such as Procrit®, Eprex®, Mircera®, Neorecormon®, Epogen®, or Aranesp™ [darbepoetin alfa] for anemia
• have not had an organ transplant and are not due to have a kidney transplant.
Participation in the PRO2TECT – CORRECTION Study will last between 1.5 and 4 years and will require regular visits to the study center. The study medication (potential new medication and approved anemia medication) and all study-related assessments will be provided at no cost to you.
If you are interested in learning more about this study
Please Call 904-730-0166
Or Sign Up Below!

I'm interested in... (Scroll to select multiple)